Cargando…
MicroRNA-181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
Autores principales: | Tian, Yifu, Fu, Xiaodan, Li, Qingling, Wang, Ying, Fan, Dan, Zhou, Qin, Kuang, Weilu, Shen, Liangfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941372/ https://www.ncbi.nlm.nih.gov/pubmed/35266013 http://dx.doi.org/10.3892/mmr.2022.12673 |
Ejemplares similares
-
MicroRNA-181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
por: Tian, Yifu, et al.
Publicado: (2018) -
microRNA-23a promotes cell growth and metastasis in gastric cancer via targeting SPRY2-mediated ERK signaling
por: Li, Yingjia, et al.
Publicado: (2021) -
Exosome-Encapsulated MicroRNA-21 from Esophageal Squamous Cell Carcinoma Cells Enhances Angiogenesis of Human Umbilical Venous Endothelial Cells by Targeting SPRY1 [Retraction]
Publicado: (2022) -
Retraction statement: MicroRNA‐21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway
Publicado: (2021) -
[Retracted] MicroRNA‑381 serves as a prognostic factor and inhibits migration and invasion in non‑small cell lung cancer by targeting LRH‑1
por: Tian, Chunyan, et al.
Publicado: (2023)